Drug profile · INN
peginterferon alfa-2a
PEGASYS
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
peginterferon alfa-2a (PEGASYS) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN peginterferon alfa-2a
Brand PEGASYS
Route SUBCUTANEOUS
Formulation VIAL
ATC code L03AB11
Frequently asked questions
What is peginterferon alfa-2a?
peginterferon alfa-2a (PEGASYS) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for peginterferon alfa-2a?
PEGASYS is a marketed brand name for peginterferon alfa-2a. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of peginterferon alfa-2a?
peginterferon alfa-2a has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.